Skip to main content
Log in

Elevated blood hemoglobin on admission as an independent predictor of unfavorable outcomes in patients with aneurysmal subarachnoid hemorrhage

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Hemoglobin (HGB), a potent spasmogen, may cause irreversible damage to the brain after aneurysm rupture. However, there is no clinical evidence to reveal the relationship between blood HGB concentrations on admission and the prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively reviewed all aSAH patients admitted to our institution between January 2015 and December 2020. Functional outcome was assessed at 90 days after discharge using the modified Rankin scale (mRS). Independent risk factors associated with 90-day unfavorable outcomes were derived from a forward stepwise multivariate analysis. Receiver operating characteristic curve analysis was conducted to identify the best cutoff value of HGB to discriminate 90-day unfavorable outcomes. Then, patients were divided into two groups according to the cutoff value of HGB, and to account for imbalances in baseline characteristics, propensity score matching (PSM) was carried out to assess the impact of HGB on in-hospital complications. A total of 800 aSAH patients without anemia on admission were retrospectively enrolled in this study. Elevated blood HGB (OR = 1.02, 95% CI = 1.00–1.03, p = 0.018) on admission was identified as an independent risk factor associated with 90-day unfavorable outcomes, and the cutoff value was 149.5 g/L. After PSM, patients with an HGB > 149.5 g/L had a higher incidence of in-hospital delayed cerebral ischemia (DCI) (33.9% vs. 22.0%, p = 0.013) and deep vein thrombosis (DVT) (11.9% vs. 4.0%, p = 0.006). Patients with a blood HGB > 149.5 g/L on admission might develop more DCI and DVT during hospitalization, leading to 90-day unfavorable outcomes in aSAH patients. ClinicalTrials.gov Identifier: NCT04785976. 2021/03/05, retrospectively registered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Availability of data and materials

The data supporting the findings of this study are available from the corresponding author upon reasonable request.

Code availability

N/A.

References

  1. Ahn SH, Savarraj JP, Pervez M, Jones W, Park J, Jeon SB, Kwon SU, Chang TR, Lee K, Kim DH, Day AL, Choi HA (2018) The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery 83:137–145. https://doi.org/10.1093/neuros/nyx364

    Article  PubMed  Google Scholar 

  2. Ayling OGS, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL (2018) Anemia after aneurysmal subarachnoid hemorrhage is associated with poor outcome and death. Stroke 49:1859–1865. https://doi.org/10.1161/strokeaha.117.020260

    Article  PubMed  Google Scholar 

  3. Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, Kim-Shapiro DB (2008) Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18:296–302. https://doi.org/10.1016/j.niox.2008.02.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, Stroke AHA, C, Council on Cardiovascular R, Intervention, Council on Cardiovascular N, Council on Cardiovascular S, Anesthesia, Council on Clinical C, (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43:1711–1737. https://doi.org/10.1161/STR.0b013e3182587839

    Article  PubMed  Google Scholar 

  5. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC (2010) Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 14:R23. https://doi.org/10.1186/cc8886

    Article  PubMed  PubMed Central  Google Scholar 

  6. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007:Cd000277. https://doi.org/10.1002/14651858.CD000277.pub3

  7. Dreier JP, Drenckhahn C, Woitzik J, Major S, Offenhauser N, Weber-Carstens S, Wolf S, Strong AJ, Vajkoczy P, Hartings JA, Group CS (2013) Spreading ischemia after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 115:125-129.https://doi.org/10.1007/978-3-7091-1192-5_26

  8. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, Reuter U, Imai Y, Einh?Upl KM, Victorov I (2000) Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 93:658-666

  9. Dreier JP, Körner K, Ebert N, Görner A, Rubin I, Back T, Lindauer U, Wolf T, Villringer A, Einhäupl KM, Lauritzen M, Dirnagl U (1998) Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 18:978–990. https://doi.org/10.1097/00004647-199809000-00007

    Article  CAS  PubMed  Google Scholar 

  10. Durmaz R, Ozkara E, Kanbak G, Arslan OC, Atasoy MA (2008) Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. Turk Neurosurg 18:157

    PubMed  Google Scholar 

  11. Faraci FM (1990) Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol 259:H1216-1221. https://doi.org/10.1152/ajpheart.1990.259.4.H1216

    Article  CAS  PubMed  Google Scholar 

  12. Foreman PM, Chua M, Harrigan MR, Fisher WS 3rd, Tubbs RS, Shoja MM, Griessenauer CJ (2015) Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: a case-control study. Clin Neurol Neurosurg 139:66–69. https://doi.org/10.1016/j.clineuro.2015.09.005

    Article  PubMed  Google Scholar 

  13. Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432–446. https://doi.org/10.1007/s12975-013-0257-2

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M (1995) The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol 277:77–87

    Article  CAS  Google Scholar 

  15. Ishiguro M, Morielli AD, Zvarova K, Tranmer BI, Penar PL, Wellman GC (2006) Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity. Circ Res 99:1252–1260. https://doi.org/10.1161/01.RES.0000250821.32324.e1

    Article  CAS  PubMed  Google Scholar 

  16. Ishiguro M, Murakami K, Link T, Zvarova K, Tranmer BI, Morielli AD, Wellman GC (2008) Acute and chronic effects of oxyhemoglobin on voltage-dependent ion channels in cerebral arteries. Acta Neurochir Suppl 104:99–102. https://doi.org/10.1007/978-3-211-75718-5_19

    Article  CAS  PubMed  Google Scholar 

  17. Jung CS, Oldfield EH, Harvey-White J, Espey MG, Zimmermann M, Seifert V, Pluta RM (2007) Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 107:945–950. https://doi.org/10.3171/JNS-07/11/0945

    Article  CAS  PubMed  Google Scholar 

  18. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP (2008) Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 36:2070–2075. https://doi.org/10.1097/CCM.0b013e31817c1095

    Article  PubMed  Google Scholar 

  19. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B (2009) Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 10:157–165

    Article  CAS  Google Scholar 

  20. Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH (2004) Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 24:916–925. https://doi.org/10.1097/01.WCB.0000125886.48838.7E

    Article  CAS  PubMed  Google Scholar 

  21. Liang CW, Su K, Liu JJ, Dogan A, Hinson HE (2015) Timing of deep vein thrombosis formation after aneurysmal subarachnoid hemorrhage. J Neurosurg 123:891–896. https://doi.org/10.3171/2014.12.JNS141288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lin G, Macdonald RL, Marton LS, Kowalczuk A, Solenski NJ, Weir BK (2001) Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide. Biochem Biophys Res Commun 280:824–830. https://doi.org/10.1006/bbrc.2000.4167

    Article  CAS  PubMed  Google Scholar 

  23. Lovelock CE, Rinkel GJ, Rothwell PM (2010) Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 74:1494–1501. https://doi.org/10.1212/WNL.0b013e3181dd42b3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Luneva OG, Brazhe NA, Fadyukova OE, Akhalaya MY, Baizhumanov AA, Parshina EY, Demidova AE, Koshelev VB, Maksimov GV (2005) Changes in plasma membrane viscosity and hemoporphyrin conformation in erythrocyte hemoglobin under the conditions of ischemia and reperfusion of rat brain. Dokl Biochem Biophys 405:465–467. https://doi.org/10.1007/s10628-005-0141-4

    Article  CAS  PubMed  Google Scholar 

  25. Macdonald RL, Weir BK (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971–982. https://doi.org/10.1161/01.str.22.8.971

    Article  CAS  PubMed  Google Scholar 

  26. Mukhtar TK, Molyneux AJ, Hall N, Yeates DR, Goldacre R, Sneade M, Clarke A, Goldacre MJ (2016) The falling rates of hospital admission, case fatality, and population-based mortality for subarachnoid hemorrhage in England, 1999–2010. J Neurosurg 125:698–704. https://doi.org/10.3171/2015.5.Jns142115

    Article  PubMed  Google Scholar 

  27. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ (2006) Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 59:775–779

    Article  Google Scholar 

  28. Naidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES, Mayer SA, Commichau C (2007) Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 35:2383–2389. https://doi.org/10.1097/01.Ccm.0000284516.17580.2c

    Article  CAS  PubMed  Google Scholar 

  29. Naidech AM, Shaibani A, Garg RK, Duran IM, Liebling SM, Bassin SL, Bendok BR, Bernstein RA, Batjer HH, Alberts MJ (2010) Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care 13:313–320. https://doi.org/10.1007/s12028-010-9424-4

    Article  PubMed  Google Scholar 

  30. Oddo M, Milby A, Chen I, Frangos S, MacMurtrie E, Maloney-Wilensky E, Stiefel M, Kofke WA, Levine JM, Le Roux PD (2009) Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke 40:1275–1281. https://doi.org/10.1161/STROKEAHA.108.527911

    Article  CAS  PubMed  Google Scholar 

  31. Ohlstein EH, Storer BL (1992) Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77:274–278. https://doi.org/10.3171/jns.1992.77.2.0274

    Article  CAS  PubMed  Google Scholar 

  32. Rass V, Helbok R (2019) Early brain injury after poor-grade subarachnoid hemorrhage. Curr Neurol Neurosci Rep 19:78. https://doi.org/10.1007/s11910-019-0990-3

    Article  PubMed  PubMed Central  Google Scholar 

  33. Sehba FA, Friedrich V (2015) Early events after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 120:23–28. https://doi.org/10.1007/978-3-319-04981-6_4

    Article  PubMed  Google Scholar 

  34. Sehba FA, Pluta RM, Zhang JH (2011) Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 43:27–40. https://doi.org/10.1007/s12035-010-8155-z

    Article  CAS  PubMed  Google Scholar 

  35. Sehba FA, Schwartz AY, Chereshnev I, Bederson JB (2000) Acute decrease in cerebral nitric oxide levels after subarachnoid hemorrhage. J Cereb Blood Flow Metab 20:604–611. https://doi.org/10.1097/00004647-200003000-00018

    Article  CAS  PubMed  Google Scholar 

  36. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 2:614–621. https://doi.org/10.1016/s1474-4422(03)00531-3

    Article  PubMed  Google Scholar 

  37. Stein M, Brokmeier L, Herrmann J, Scharbrodt W, Schreiber V, Bender M, Oertel MF (2015) Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction. J Clin Neurosci 22:530–534. https://doi.org/10.1016/j.jocn.2014.08.026

    Article  CAS  PubMed  Google Scholar 

  38. Sun J, Tan G, Xing W, He Z (2015) Optimal hemoglobin concentration in patients with aneurysmal subarachnoid hemorrhage after surgical treatment to prevent symptomatic cerebral vasospasm. NeuroReport 26:263–266. https://doi.org/10.1097/WNR.0000000000000340

    Article  CAS  PubMed  Google Scholar 

  39. Treggiari MM, Deem S (2009) Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care 15:83–86

    Article  Google Scholar 

  40. Treggiari MM, Walder B, Suter PM, Romand J-A (2003) Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978–984

    Article  Google Scholar 

  41. Vallance P, Chan N (2001) Endothelial function and nitric oxide: clinical relevance. Heart 85:342–350. https://doi.org/10.1136/heart.85.3.342

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Velat GJ, Kimball MM, Mocco JD, Hoh BL (2011) Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 76:446–454. https://doi.org/10.1016/j.wneu.2011.02.030

    Article  PubMed  Google Scholar 

  43. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA (2006) Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34:617–623; quiz 624. https://doi.org/10.1097/01.ccm.0000201903.46435.35

  44. Xiao A, Chen R, Ren Y, You C (2019) Elevated hemoglobin is associated with poor prognosis in Tibetans with poor-grade aneurysmal subarachnoid hemorrhage after clipping: A Retrospective Case-Control Study. Neurochirurgie 65

Download references

Acknowledgements

We thank all the staff and participants for their contribution to this study.

Funding

This study was supported by the National Key Research and Development Program of China (Grant Nos. 2021YFC2501101 and 2020YFC2004701) and the National Natural Science Foundation of China (Grant Nos. 82071296, 81671129, and 81471210).

Author information

Authors and Affiliations

Authors

Contributions

Conception and design: Xiaolin Chen, Yuanli Zhao. Acquisition of data: Runting Li, Fa Lin, Yu Chen, Junlin Lu, Heze Han, Li Ma, Yahui Zhao, Debin Yan, Ruinan Li, Jun Yang, Shihao He, Zhipeng Li, Haibin Zhang, Kexin Yuan, Ke Wang, Hongliang Li, Linlin Zhang, Yang Zhao, Yukun Zhang. Analysis and interpretation of data: all authors. Drafting the article: Runting Li. Reviewed the submitted version of manuscript: Xiaolin Chen, Yuanli Zhao. Statistical analysis: Runting Li, Fa Lin, Yu Chen, Junlin Lu, Qiang Hao. Administrative/technical/material support: Youxiang Li, Shuo Wang, Guangzhi Shi, Jianxin Zhou. Study supervision: Xiaolin Chen, Yuanli Zhao.

Corresponding authors

Correspondence to Xiaolin Chen or Yuanli Zhao.

Ethics declarations

Ethics approval

This study was approved by the Institutional Review Board of Beijing Tiantan Hospital (KY 2021–008-01). All the analyses were performed according to the Declaration of Helsinki and the local ethics policies.

Consent to participate

Informed consent for clinical analysis was obtained from all individual participants or their authorized representatives.

Consent for publication

All authors read and approved the final manuscript.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, R., Lin, F., Chen, Y. et al. Elevated blood hemoglobin on admission as an independent predictor of unfavorable outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev 45, 2689–2699 (2022). https://doi.org/10.1007/s10143-022-01780-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-022-01780-w

Keywords

Navigation